Bariatrics clinical trial - Rhythm Pharmaceuticals, Inc. - DAYBREAK

Bariatrics

Status:

Startup

ClinicalTrials.gov:

NCT04963231

Rhythm Pharmaceuticals, Inc.  - RM-493-034: DAYBREAK

Drug

Setmelanotide/Placebo

Phase

III

Condition

Obesity